XTENT Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 115

Employees

  • Latest Deal Type
  • M&A

XTENT General Information

Description

Developer of customizable drug-eluting stent (DES) systems for the treatment of coronary artery disease. The company's customizable DES systems are designed to enable physicians to customize both length and diameter of the stent at the site of the diseased section of the artery, or lesion.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 125 Constitution Drive
  • Menlo Park, CA 94025
  • United States
+1 (650)
Primary Industry
Surgical Devices
Acquirer
JW Medical
Corporate Office
  • 125 Constitution Drive
  • Menlo Park, CA 94025
  • United States
+1 (650)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

XTENT Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 01-Jan-2009 Completed Generating Revenue
6. IPO 01-Feb-2007 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Later Stage VC (Series D) 22-Jan-2007 Completed Generating Revenue
3. Later Stage VC (Series C) 03-Mar-2006 Completed Generating Revenue
2. Early Stage VC (Series B) 02-Jun-2003 $15.2M $20.5M Completed Generating Revenue
1. Early Stage VC (Series A) 17-Mar-2003 $5.28M $5.28M Completed Product Development
To view XTENT’s complete valuation and funding history, request access »

XTENT Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D
Series C
Series B 4,051,052 $0.001000 $0.3 $3.76 $3.76 1x $3.76 16.4%
Series A 2,637,500 $0.001000 $0.16 $2 $2 1x $2 10.68%
To view XTENT’s complete cap table history, request access »

XTENT Patents

  • 130

    Total Documents Applications and Grants

  • Total Patents Families

  • 15

    Granted

  • Pending

  • Expiring in next 12 mo

XTENT Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20090076584-A1 Apparatus and methods for deployment of multiple custom-length prostheses Inactive 19-Sep-2007
US-20080199510-A1 Structure implanted into body tissue; heat sensitive elements; particles dispersed in structure irradiated with electromagnetic waves Inactive 20-Feb-2007
AU-2008218719-A1 Thermo-mechanically controlled implants and methods of use Inactive 20-Feb-2007
CA-2678814-A1 Thermo-mechanically controlled implants and methods of use Inactive 20-Feb-2007
US-20080269865-A1 Custom length stent apparatus Inactive 07-Aug-2006 A61F2/958
To view XTENT’s complete patent history, request access »

XTENT Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

XTENT Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Adams Street Partners PE/Buyout Minority
Advanced Technology Ventures Venture Capital Minority
Latterell Venture Partners Venture Capital Minority
Morgenthaler Ventures Venture Capital Minority
Split Rock Partners Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

XTENT FAQs

  • When was XTENT founded?

    XTENT was founded in 2002.

  • Where is XTENT headquartered?

    XTENT is headquartered in Menlo Park, CA.

  • What is the size of XTENT?

    XTENT has 115 total employees.

  • What industry is XTENT in?

    XTENT’s primary industry is Surgical Devices.

  • Is XTENT a private or public company?

    XTENT is a Private company.

  • What is XTENT’s current revenue?

    The current revenue for XTENT is .

  • How much funding has XTENT raised over time?

    XTENT has raised $152M.

  • Who are XTENT’s investors?

    Adams Street Partners, Advanced Technology Ventures, Latterell Venture Partners, Morgenthaler Ventures, and Split Rock Partners are 5 of 6 investors who have invested in XTENT.

  • When was XTENT acquired?

    XTENT was acquired on 01-Jan-2009.

  • Who acquired XTENT?

    XTENT was acquired by JW Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »